The evidence across in vitro, in vivo and clinical research indicates that, upon the progression of IHD, there was extensive release of inflammatory mediators and DAMPs, which induced the priming of inflammasomes predominantly through TLR4/Myd88/NF‐κB/p65 signalling cascades. The gene discussed is NFKB1; the disease is myocardial ischemia.